Role of the acid sphingomyelinase/ ceramide system in post-ischemic angiogenesis and brain remodeling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 161 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Duisburg, Essen, Universität Duisburg-Essen, Dissertation, 2020
- Schlagwort
-
Schlaganfall
Tiermodell
Therapie
Ischämie
- Ereignis
-
Veröffentlichung
- (wo)
-
Duisburg, Essen
- (wer)
-
Universität Duisburg-Essen
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.17185/duepublico/73097
- URN
-
urn:nbn:de:hbz:465-20220906-144336-7
- Rechteinformation
-
Open Access unbekannt; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mohamud Yusuf, Ayan
- Hermann, Dirk Matthias
- Universität Duisburg-Essen
Entstanden
- 2022
Ähnliche Objekte (12)
Acid sphingomyelinase deficiency ameliorates Farber disease
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
The acid sphingomyelinase/ceramide system in COVID-19
Role of acid sphingomyelinase in T lymphocyte activation
Acid Sphingomyelinase Is a Modulator of Contextual Fear
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Acid sphingomyelinase is required for efficient phago-lysosomal fusion
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Characterization of ARC39, a new inhibitor of acid sphingomyelinase
Identification of novel clinical applications for acid sphingomyelinase inhibitors
Acid sphingomyelinase deficiency ameliorates Farber disease
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
The acid sphingomyelinase/ceramide system in COVID-19
Role of acid sphingomyelinase in T lymphocyte activation
Acid Sphingomyelinase Is a Modulator of Contextual Fear
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Acid sphingomyelinase is required for efficient phago-lysosomal fusion
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Characterization of ARC39, a new inhibitor of acid sphingomyelinase
Identification of novel clinical applications for acid sphingomyelinase inhibitors
Acid sphingomyelinase deficiency ameliorates Farber disease
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
The acid sphingomyelinase/ceramide system in COVID-19
Role of acid sphingomyelinase in T lymphocyte activation
Acid Sphingomyelinase Is a Modulator of Contextual Fear
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Acid sphingomyelinase is required for efficient phago-lysosomal fusion
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Characterization of ARC39, a new inhibitor of acid sphingomyelinase